CMS transparency rules and AI could bring “Expedia-like” drug price comparisons for consumers, but payer compliance to transparency rules remains low.
News|Articles|September 1, 2001
Metformin prevents diabetes in high-risk subjects, but effect is trumped by lifestyle changes
For the first time, a large clinical trial has shown that a medication can help prevent type 2 diabetes in high-risk individuals. At the same time, drug therapy emerged as a less effective preventive strategy than fairly modest diet and exercise changes.
Advertisement
Advertisement
Related to this article
Onswik is approved to improve glycemic control in adults with Type 2 diabetes and will be available in the United States in the coming months in two concentrations. No information is available on the list price.
A new Spherix Global Insights survey shows providers want administrative support for prior authorization while patients prioritize access and affordability
UCLA research suggests that GLP-1 therapies may protect bone health in Type 2 diabetes patients.
Pharmacy benefit managers are moving beyond formulary access to provide support programs for women's health. Here's how three PBMs — Judi Health, LucyRx and RxPreferred — are putting that strategy into practice.
Women face more gaps in healthcare than men, from missed screenings, undertreatment and biased coverage. PBMs are launching programs to address some of the gaps.
Dunn of NeosRx says a 340B shift from discounts to rebates likely won't affect rebate erosion affecting plan sponsors.
Five transcranial magnetic stimulation sessions in one day improved processing speed in adults with schizophrenia, which holds promise for future treatment possibilities, according to researcher Heather Burrell Ward, M.D.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Heather Burrell Ward, M.D., on personalizing TMS in schizophrenia
2
Teledentistry is a step in closing the gap in dental care
3
FDA approves Lilly’s Onswik, the second once-weekly insulin
4
Texas A&M researchers discover promising therapy for fatty liver disease
5